Marcus Bauser
Janssen (Belgium)(BE)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Biochemical and Molecular Research, Chemical Synthesis and Analysis, HIV/AIDS drug development and treatment, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876(2016)263 cited
- → The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies(2019)239 cited
- → Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo(2017)118 cited
- → Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance(2018)106 cited
- → New Class of Bacterial Phenylalanyl-tRNA Synthetase Inhibitors with High Potency and Broad-Spectrum Activity(2004)77 cited
- → Sequential Nitration/Hydrogenation Protocol for the Synthesis of Triaminophloroglucinol: Safe Generation and Use of an Explosive Intermediate under Continuous-Flow Conditions(2014)63 cited
- → Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target(2017)57 cited
- → Preclinical Profile of Gadoquatrane(2022)52 cited
- → 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi(2017)51 cited
- → Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability(2014)49 cited